Gene | Disease | Score gda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
0.100 | GeneticVariation | CLINVAR | Phenotypic and molecular characterisation of CDK13-related congenital heart defects, dysmorphic facial features and intellectual developmental disorders. | 28807008 | 2017 |
||||||||
|
|
0.100 | GeneticVariation | CLINVAR | Novel mutation in CNTNAP1 results in congenital hypomyelinating neuropathy. | 27668699 | 2017 |
||||||||
|
|
0.100 | CausalMutation | CLINVAR | Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. | 16474404 | 2006 |
||||||||
|
|
0.100 | CausalMutation | CLINVAR | Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. | 16439621 | 2006 |
||||||||
|
|
0.100 | GeneticVariation | CLINVAR | First missense mutation (W679R) in exon 10 of the adrenoleukodystrophy gene in siblings with adrenomyeloneuropathy. | 9452087 | 1998 |
||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | GeneticVariation | CLINVAR | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | CausalMutation | CLINVAR | |||||||||||
|
|
0.100 | GeneticVariation | CLINVAR |